Login / Signup

Complete Response in a Patient With Chemorefractory EGFR-Amplified, PD-L1-Positive Metastatic Gastric Cancer Treated By Dual Anti-EGFR and Anti-PD-1 Monoclonal Antibody Therapy.

Natalie M ReizineBryan PetersonStephanie MoyaYan WangYi-Hung Carol Y H TanOliver S EngMalcolm BilimoriaErnst LengyelKiran Kalyan TuragaDaniel V T Catenacci
Published in: JCO precision oncology (2020)
Keyphrases
  • monoclonal antibody
  • small cell lung cancer
  • epidermal growth factor receptor
  • tyrosine kinase
  • squamous cell carcinoma
  • case report
  • metastatic colorectal cancer
  • newly diagnosed
  • cell therapy
  • mesenchymal stem cells